Whan In Pharm Co.,Ltd.

KSE 016580.KS

Whan In Pharm Co.,Ltd. Operating Cash Flow for the year ending December 31, 2023: USD 17.82 M

Whan In Pharm Co.,Ltd. Operating Cash Flow is USD 17.82 M for the year ending December 31, 2023, a 33.82% change year over year. Operating cash flow is cash generated from the company’s regular business operations.

Whan In Pharm Co.,Ltd. Operating Cash Flow for the year ending December 31, 2022 was USD 13.31 M, a -54.97% change year over year.
Whan In Pharm Co.,Ltd. Operating Cash Flow for the year ending December 31, 2021 was USD 29.56 M, a 41.52% change year over year.
Whan In Pharm Co.,Ltd. Operating Cash Flow for the year ending December 31, 2020 was USD 20.89 M, a -2.01% change year over year.
Whan In Pharm Co.,Ltd. Operating Cash Flow for the year ending December 31, 2019 was USD 21.32 M, a 36.61% change year over year.

Key data

Date	Operating Cash Flow	Net Cash Used For Investing Activities	Net Cash Used Provided By Financing Activities	Dividends Paid

KSE: 016580.KS

Whan In Pharm Co.,Ltd.

CEO	Mr. Wonbum Lee
IPO Date	Jan. 4, 2000
Location	South Korea
Headquarters	Whanin Building, 11
Employees	582
Sector	Healthcare
Industries Pharmaceuticals Biotechnology Cosmetics Drugstores & Retail Pharmacies Personal Care

Description

Whan In Pharm Co.,Ltd., a pharmaceutical company, develops, manufactures, markets, and sells therapeutic products in South Korea. It offers anti-depressants, anti-psychotics, nootropics and anti-dementia, anti-epileptics, cardiovascular, gastrointestinal, antibiotics, antiviral agents, antihistamines, anti-inflammatory and analgesics, metabolic disorders, respiratory, central nervous system, other drug products. The company was founded in 1978 and is headquartered in Seoul, South Korea.

Key trends

Past 5 years